<?xml version="1.0" encoding="UTF-8"?>
<ref id="B59-vaccines-07-00070">
 <label>59.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Macagno</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Bernasconi</surname>
    <given-names>N.L.</given-names>
   </name>
   <name>
    <surname>Vanzetta</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Dander</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Sarasini</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Revello</surname>
    <given-names>M.G.</given-names>
   </name>
   <name>
    <surname>Gerna</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Sallusto</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Lanzavecchia</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex</article-title>
  <source>J. Virol.</source>
  <year>2010</year>
  <volume>84</volume>
  <fpage>1005</fpage>
  <lpage>1013</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.01809-09</pub-id>
  <pub-id pub-id-type="pmid">19889756</pub-id>
 </element-citation>
</ref>
